Bjerke, Donald L.
40  results:
Search for persons X
?
1

A framework to mitigate the risk of chemical leukoderma: Co..:

Bjerke, Donald L. ; Wu, Shengde ; Wakamatsu, Kazumasa...
Regulatory Toxicology and Pharmacology.  131 (2022)  - p. 105157 , 2022
 
?
2

Cover Image:

Bjerke, Donald L. ; Li, Rui ; Price, Jason M....
Experimental Dermatology.  30 (2021)  2 - p. , 2021
 
?
 
?
4

Use of read-across and computer-based predictive analysis f..:

Skare, Julie A. ; Blackburn, Karen ; Wu, Shengde...
Regulatory Toxicology and Pharmacology.  71 (2015)  3 - p. 515-528 , 2015
 
?
5

Can acute dermal systemic toxicity tests be replaced with o..:

Moore, Nigel P. ; Andrew, David J. ; Bjerke, Donald L....
Regulatory Toxicology and Pharmacology.  66 (2013)  1 - p. 30-37 , 2013
 
?
6

Case studies to test: A framework for using structural, rea..:

Blackburn, Karen ; Bjerke, Donald ; Daston, George...
Regulatory Toxicology and Pharmacology.  60 (2011)  1 - p. 120-135 , 2011
 
?
10

In utero and lactational exposure of male rats to 2,3,7,8-t..:

Mably, Thomas A. ; Bjerke, Donald L. ; Moore, Robert W...
Toxicology and Applied Pharmacology.  114 (1992)  1 - p. 118-126 , 1992
 
?
 
?
13

Can Acute Dermal Systemic Toxicity Tests Be Replaced With O..:

Moore, Nigel P ; Andrew, David J ; Bjerke, Donald L...
https://www.wellbeingintlstudiesrepository.org/acwp_arte/45.  , 2013
 
?
14

Small airways in progressive systemic sclerosis (PSS):

Bjerke, Randal D. ; Tashkin, Donald P. ; Clements, Philip J....
The American Journal of Medicine.  66 (1979)  2 - p. 201-209 , 1979
 
1-15